Polymorphism of CYP450 and cancer susceptibility

Acta Pharmacologica Sinica

Volumn 21, Issue 8, 2000, Pages 673-679

  Han, X M ^a   Zhou, H H ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Cytochrome P 450; Disease Susceptibility; Genotype; Phenotype; Polymorphism (genetics)

Indexed keywords

CYTOCHROME P450; DRUG;

CANCER; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; DRUG METABOLISM; ENZYME SUBSTRATE COMPLEX; GENETIC POLYMORPHISM; HUMAN; REVIEW;

BREAST NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CYTOCHROME P-450 ENZYME SYSTEM; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 0033875496     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. P450 superfamily: Update on new sequence, gene mapping, accession numbers and nomenclature
2. Induction and developmental expression of cytochrome P4501A1 messenger RNA in rat and human tissues: Detection by the polymerase chain reaction
3. Induction of cytochrome P4501A1
4. Genetic polymorphism of induction of CYP1A1 (EROD) activity
5. Identification of genetically high risk individuals to lung cancer by DNA polymorphism of the cytochrome P4501A1 gene
6. Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers
7. Cytochrome P4501A2 in drug metabolism
8. Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population
9. Detection of three genetic polymorphisms in the 5'-flanking region and intron 1 of human CYP1A2 in the Japanese population
10. Genetic polymorphism in the 5'-flanking region of human CYP1A2 gene: Effect on the CYP1A2 inducibility in human
11. Functional significance of a C→A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine
12. CYP1A2-catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans
13. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4
14. Biochemistry and molecular biology of human CYP1A2 subfamily
15. High performance liquid chromatography determination of urinary 4'-hydroxymephenytoin: A metabolic marker for the hepatic enzyme CYP2C19 in humans
16. The major defect responsible for the polymorphism of S-mephenytoin metabolism in humans
17. Identification of a new genetic defect responsible for the polymorphism of S-mephenytoin metabolism in Japanese
18. Individual and ethnic differences in CYP2C19 activity in Chinese populations
19. The induction effect of rifampicin on activity of mephenytoin 4'-hydroxylase related to ml mutation of CYP2C19 and gene dose
20. In vivo inhibition of CYP2C19 but not CYP2D6 by fluvoxamine
21. Genetic polymorphism of drug metabolism
22. Polymorphic hydroxylation of debrisoquine in man
23. Comparative evolutionary pharmacogenetics of CYP2D6 in Ngawbe and Embera Amerindians of Panama and Colombia: Role of selection versus drift in world populations
24. Study of the association between cytochromes P450 2D6 and 2E1 genotypes and the risk of drug and chemical induced idiosyncratic aplastic anaemia
25. A tobacco smoke derived nitrosamine 4-(methylnitrosoamino)- 1- (3-pyridyl)- 1-butanone is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6
26. Metabolic oxidation phenotypes as markers for susceptibility to lung cancer
27. CYP2D6 gene and risk of liver cancer
28. Detection of CYP2D6*3 and 2D6*4 allelic variants by PCR-restriction fragment length polymorphism
29. Recent advance of cytochrome P4502E1
30. Expression of cytochrome P4502E1 in human liver: Assessment by mRNA, genotype and phenotype
31. Different regulation and expression of the human CYP2E1 gene due to the Rsa I polymorphism in the 5'-flanking region
32. Pst I and Rsa I RFLPs in complete linkage disequilibrium at the CYP2E1 gene
33. Association between restriction fragment length polymorphism of human cytochrome P4502E1 gene and susceptibility to lung cancer
34. Genetic polymorphism of human CYP2E1: Characterization of two variant alleles
35. Role of human cytochrome P4502E1 in the oxidation of many low molecular weight cancer suspects
36. Cytochrome P4502E1 and glutathione S-transferase M: Polymorphisms and susceptibility to hepato cellular carcinoma
37. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan
38. Genetic polymorhism of CYP2E1 in a Swedish population. Relationship to the occurrence of lung cancer
39. The human CYP2E1 gene and lung cancer: Dral and Rsal restriction fragment length polymorphisms in a Finnish study population
40. Cytochrome P4503A4 and drug metabolism
41. Failure of erythromycin breath test to correlate with midazolam clearance as a probe for cytochrome P4503A
42. Population distribution and effects on drug metabolism of a genetic variant in the 5' promotor region of CYP3A4
43. Low activity of dapsone hydroxylation is a susceptibility risk factor in aggressive bladder cancer
44. Association of low CYP3A activity with p53 mutation and CYP2D6 activity with Rb mutation in human bladder cancer
45. Genetic polymorphism of toxin metabolizing enzymes and susceptibility to hepatocelluar carcinoma